BR112016021231B1 - Composto derivado de hexose, composição e método de estabilização de um material biológico - Google Patents

Composto derivado de hexose, composição e método de estabilização de um material biológico Download PDF

Info

Publication number
BR112016021231B1
BR112016021231B1 BR112016021231-2A BR112016021231A BR112016021231B1 BR 112016021231 B1 BR112016021231 B1 BR 112016021231B1 BR 112016021231 A BR112016021231 A BR 112016021231A BR 112016021231 B1 BR112016021231 B1 BR 112016021231B1
Authority
BR
Brazil
Prior art keywords
compound
mmol
experiment
biological material
salt
Prior art date
Application number
BR112016021231-2A
Other languages
English (en)
Portuguese (pt)
Other versions
BR112016021231A2 (en
Inventor
Christopher David Maycock
Maria Rita Mendes Bordalo Ventura Centeno Lima
Eva Correia Lourenço
Maria Helena Dias Dos Santos
Ana Sofia Da Cunha Miguel
Original Assignee
Faculdade De Ciências Da Universidade De Lisboa
Instituto De Tecnologia Química E Biológica António Xavier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Faculdade De Ciências Da Universidade De Lisboa, Instituto De Tecnologia Química E Biológica António Xavier filed Critical Faculdade De Ciências Da Universidade De Lisboa
Publication of BR112016021231A2 publication Critical patent/BR112016021231A2/en
Publication of BR112016021231B1 publication Critical patent/BR112016021231B1/pt

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/02—Acyclic radicals, not substituted by cyclic structures
    • C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H9/00—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical
    • C07H9/06—Compounds containing a hetero ring sharing at least two hetero atoms with a saccharide radical the hetero ring containing nitrogen as ring hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/107—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides
    • C07K1/113—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure
    • C07K1/1136—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length by chemical modification of precursor peptides without change of the primary structure by reversible modification of the secondary, tertiary or quarternary structure, e.g. using denaturating or stabilising agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/96—Stabilising an enzyme by forming an adduct or a composition; Forming enzyme conjugates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Immunology (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Saccharide Compounds (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
BR112016021231-2A 2014-03-14 2015-03-13 Composto derivado de hexose, composição e método de estabilização de um material biológico BR112016021231B1 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201461953392P 2014-03-14 2014-03-14
US61/953,392 2014-03-14
PCT/PT2015/050001 WO2015137838A1 (en) 2014-03-14 2015-03-13 Hexose derivatives, preparation and uses thereof

Publications (2)

Publication Number Publication Date
BR112016021231A2 BR112016021231A2 (en) 2018-07-10
BR112016021231B1 true BR112016021231B1 (pt) 2021-07-27

Family

ID=53264710

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112016021231-2A BR112016021231B1 (pt) 2014-03-14 2015-03-13 Composto derivado de hexose, composição e método de estabilização de um material biológico

Country Status (12)

Country Link
US (2) US11708387B2 (https=)
EP (1) EP3116886A1 (https=)
JP (2) JP7067867B2 (https=)
KR (3) KR102651029B1 (https=)
CN (2) CN106573952A (https=)
BR (1) BR112016021231B1 (https=)
CA (1) CA2942635C (https=)
IL (1) IL247531B (https=)
MX (1) MX386787B (https=)
RU (1) RU2731563C2 (https=)
SG (2) SG10201807891UA (https=)
WO (1) WO2015137838A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102651029B1 (ko) * 2014-03-14 2024-03-25 파쿠우다지 지 씨엔씨아스 다 우니베르시다지 지 리스보아 헥소스 유도체, 그의 제제 및 용도
FR3061013B1 (fr) * 2016-12-22 2020-04-17 Greenpharma Composition contenant le digeneaside, son procede d'obtention et son utilisation cosmetique, veterinaire ou nutraceutique
US12098162B2 (en) * 2017-11-13 2024-09-24 Extremochem, Lda Neutral glycosylated amides and dianionic glucuronidated acids as stabilizers for biological molecules
CN116251110B (zh) * 2022-11-18 2025-02-14 广东药科大学 β-D-吡喃葡萄糖基-乳酸及其衍生物在制备治疗代谢性疾病、炎症药物中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060099567A1 (en) * 2004-04-08 2006-05-11 Biomatrica, Inc. Integration of sample storage and sample management for life science
DE102004031588A1 (de) * 2004-06-30 2006-02-09 Symrise Gmbh & Co. Kg Verwendung von Äpfelsäureglucosiden als Geschmacksstoffe
PT103442A (pt) * 2006-02-24 2007-08-31 Stab Vida Investigacao E Servi Derivados sintéticos de manosil-glicerato para a estabilização e/ou preservação de biomateriais
PT103441A (pt) 2006-02-24 2007-08-24 Stab Vida Investigacao E Servi Utilização de solutos compatíveis para melhorar o desempenho de técnicas utilizando materiais biológicos imobilizados
DE102010038496A1 (de) 2010-07-27 2012-02-02 Henkel Ag & Co. Kgaa Stabilisierte flüssige enzymhaltige Tensidzubereitung
DE102011118027A1 (de) * 2011-09-12 2013-03-14 Henkel Ag & Co. Kgaa Verfahren zur Anpassung eines Hydrolytischen Enzyms an eine das hydrolytische Enzym stabilisierende Komponente
KR102651029B1 (ko) 2014-03-14 2024-03-25 파쿠우다지 지 씨엔씨아스 다 우니베르시다지 지 리스보아 헥소스 유도체, 그의 제제 및 용도
JP2020097767A (ja) 2018-12-18 2020-06-25 株式会社東芝 表面処理剤、これを用いた積層体、及び無電解めっき製品

Also Published As

Publication number Publication date
SG11201607530XA (en) 2016-10-28
KR102401853B1 (ko) 2022-05-25
US12590117B2 (en) 2026-03-31
JP7077361B2 (ja) 2022-05-30
US20230357301A1 (en) 2023-11-09
IL247531A0 (en) 2016-11-30
CA2942635A1 (en) 2015-09-17
KR20220153571A (ko) 2022-11-18
KR20240045328A (ko) 2024-04-05
JP2017516838A (ja) 2017-06-22
SG10201807891UA (en) 2018-10-30
EP3116886A1 (en) 2017-01-18
MX386787B (es) 2025-03-19
US20180170955A1 (en) 2018-06-21
IL247531B (en) 2021-04-29
JP2020183383A (ja) 2020-11-12
CA2942635C (en) 2022-12-06
RU2016140337A3 (https=) 2018-10-30
CN106573952A (zh) 2017-04-19
KR20160145584A (ko) 2016-12-20
BR112016021231A2 (en) 2018-07-10
KR102651029B1 (ko) 2024-03-25
CN115448964A (zh) 2022-12-09
US11708387B2 (en) 2023-07-25
KR102828884B1 (ko) 2025-07-02
JP7067867B2 (ja) 2022-05-16
MX2016011808A (es) 2017-05-09
RU2016140337A (ru) 2018-04-17
RU2731563C2 (ru) 2020-09-04
WO2015137838A1 (en) 2015-09-17

Similar Documents

Publication Publication Date Title
US12590117B2 (en) Hexose derivatives, preparation and uses thereof
ES3054438T3 (en) Cationic lipids for use in lipid nanoparticles
US11542225B2 (en) Lipids for use in lipid nanoparticle formulations
ES2938557T3 (es) Lípidos y formulaciones de nanopartículas lipídicas novedosos para la entrega de ácidos nucleicos
Lijinsky et al. Mechanism of alkylation of nucleic acids by nitrosodimethylamine
Wilkinson et al. The extracellular polysaccharide of Aerobacter aerogenes A3 (S1)(Klebsiella type 54)
IL324315A (en) Lipids for use in lipid nanoparticle formulations
Wang et al. Synthesis of a suite of click-compatible sugar analogs for probing carbohydrate metabolism
Wallace et al. Red algal molecules-Synthesis of methyl neo-β-carrabioside and its S-linked variant via two synthetic routes: a late stage ring closure and using a 3, 6-anhydro-D-galactosyl donor
WO2025124711A1 (en) Glycolipid compositions
HK40084341A (en) Hexose derivatives, preparation and uses thereof
Schombs et al. Glycochemistry: overview and progress
HK1236538A1 (en) Hexose derivatives, preparation and uses thereof
Lourenço Synthesis of new enzyme stabilisers inspired by compatible solutes of hyperthermophilic microorganisms
JP2007084484A (ja) 皮膚外用剤
EP4667500A1 (en) Fructooligosaccharide derivatives and uses thereof
US20250101338A1 (en) Biomass derived surface-active compositions and products
Louda et al. Biochemistry Review: Overview of Biomolecules
Vorob’eva et al. Some peculiarities of the outer membrane composition of marine Gram-negative bacterium Chryseobacterium indoltheticum CIP 103168T
Verhart Some approaches to the innovative chemical use of sucrose and related monosaccharides
Lamosa et al. A unique glyceryl diglycoside identified in the thermophilic, radiation-resistant bacterium Rubrobacter xylanophilus
II Characterization and biological activity of bacterial glycoconjugates in cold adaptation.
Muthana Chemoenzymatic synthesis of sialic acid-containing carbohydrates
PT108345A (pt) Processos para produção de intermediários acilados de polissacáridos micobacterianos essenciais
JPWO2005095428A1 (ja) バクテリアの効率的表面修飾方法

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06U Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 13/03/2015, OBSERVADAS AS CONDICOES LEGAIS.

B25A Requested transfer of rights approved

Owner name: FACULDADE DE CIENCIAS DA UNIVERSIDADE DE LISBOA (PT) ; UNIVERSIDADE NOVA DE LISBOA (PT)